Re-Identification of Patient Subgroups in Uveal Melanoma
Uveal melanoma (UM) is a comparatively rare cancer but requires serious consideration since patients with developing metastatic UM survive only for about 6–12 months. Fortunately, increasingly large multi-omics databases allow us to further understand cancer initiation and development. Moreover, pre...
Main Authors: | Thi Hai Yen Nguyen, Tin Nguyen, Quang-Huy Nguyen, Duc-Hau Le |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.731548/full |
Similar Items
-
Multi-Omics Analysis Detects Novel Prognostic Subgroups of Breast Cancer
by: Quang-Huy Nguyen, et al.
Published: (2020-10-01) -
S100 as Serum Tumor Marker in Advanced Uveal Melanoma
by: Martin Salzmann, et al.
Published: (2023-03-01) -
Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma
by: Johanna Matull, et al.
Published: (2024-06-01) -
Аngiogenesis in Uveal Melanoma
by: V. G. Likhvantseva, et al.
Published: (2021-10-01) -
Brachytherapy in the Management of Uveal Melanomas
by: Samuray Tuncer
Published: (2014-09-01)